Quick Listen: Scrip’s Five Must-Know Things
Join us for an audio catch-up of the past week's main biopharma events as brought to you by Scrip's global team, in this mini podcast version of Five Must-Know Things.
This episode includes the main news from around the biopharma world in the business week ended 11 December 2020.
Important updates from the ASH meeting, the latest developments with COVID-19 vaccines, and new ambitions at Japan's largest pharma firm are all on the menu this time.
Stories mentioned in this episode:
(Also see "ASH 2020: J&J/Legend’s Cilta-Cel Shines, But BMS/Bluebird’s Ide-Cel Is In First Place" - Scrip, 5 Dec, 2020.)
(Also see "ASH 2020: Novel CAR-T Approaches Chase BCMA-Targeting Frontrunners" - Scrip, 8 Dec, 2020.)
(Also see "J&J's Gorsky On Janssen's COVID-19 Vaccine Timeline, Scale-Up and Back Story" - Scrip, 7 Dec, 2020.)
(Also see "Last Minute Allocation Shake Up? Pfizer’s One-Dose Data Could Change COVID-19 Vaccine Rollout" - Scrip, 8 Dec, 2020.)
(Also see "Takeda Looks To Ride 'Wave 1' To JPY5tn Target" - Scrip, 8 Dec, 2020.)
These and all Informa Pharma Intelligence podcasts are available on SoundCloud, Apple Podcasts, TuneIn and Google Play and also via smart speakers - just make sure one of these providers is set up as your default for podcasts, and then ask for "Pharma Intelligence podcasts".